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Abstract
Accurate diagnosis of infection with the parasite Strongyloides stercoralis is hampered by the low concentration of larvae in
stool, rendering parasitological diagnosis insensitive. Even if the more sensitive agar plate culture method is used repeated
stool sampling is necessary to achieve satisfactory sensitivity. In this manuscript we describe the development of a
coproantigen ELISA for diagnosis of infection. Polyclonal rabbit antiserum was raised against Strongyloides ratti excretory/
secretory (E/S) antigen and utilized to develop an antigen capture ELISA. The assay enabled detection of subpatent rodent
S. ratti and human S. stercoralis infection. No cross-reactivity was observed with purified E/S from Schistosoma japonicum,
the hookworms Ancylostoma caninum, A. ceylanicum, nor with fecal samples collected from rodents harboring Trichuris
muris or S. mansoni infection. Strongyloides coproantigens that appear stable when frozen as formalin-extracted fecal
supernatants stored at 220uC remained positive up to 270 days of storage, whereas supernatants stored at 4uC tested
negative. These results indicate that diagnosis of human strongyloidiasis by detection of coproantigen is an approach
worthy of further development.
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Introduction
The diagnosis of gastrointestinal infections typically relies on
either empirical clinical diagnosis, or demonstration of the
pathogen using standard microbiological techniques. However, a
number of important gastrointestinal pathogens are difficult to
detect using such techniques, and in some of these infections such
as amoebiasis and strongyloidiasis, a potentially life-threatening
pathogen may be present despite few or no clinical symptoms and
negative diagnostic tests.
Serological diagnosis by ELISA [1,2] and agar plate copro-
culture [1,2] are currently the standard techniques used for
parasitalogical diagnosis of infection with Strongyloides stercoralis.
Agar plate coproculture has been reported to show high sensitivity
and specificity. However, it requires a 24–48 hours incubation
time, an experienced technician to correctly identify the larvae,
and can represent a biohazard to the laboratory scientist [1,2].
While serologic diagnosis, usually by ELISA is highly sensitive [3],
specificity can be low due to the persistence of antibodies from
previous infection or cross-reactive antibodies [4].
Coproantigen assays have been developed for the diagnosis of a
range of human and animal intestinal infections. In general
antibodies raised against whole parasite extracts are coated on
microtiter plates, and subsequently fecal antigen is captured and
detected with the same or second parasite-specific antibody in a
capture assay [5,6]. The use of monoclonal antibodies is generally
believed to increase both the sensitivity and the specificity of such
assays [7–10].
Examples of coproantigen ELISAs developed for the detection
of a range of intestinal infections include amoebiasis [11–13],
bacterial and viral gastroenteritis [14], trematodes [15] and
cestodes [16,17]. Of note, the more successful coproantigen assays
have been developed against intestinal infections with either large
parasites or pathogens with a likely high fecal antigen load.
However, coproantigen detection is not limited to diagnosis of
intestinal infections, as it has also been applied to the detection of
gastric adenocarcinoma [18] and the detection of fecal occult
blood [19]. Another advantage of such coproantigen assays is the
ability to detect cryptic or pre-patent infections [6,20].
In the case of nematode infections, a number of assays have
been reported for the detection of animal host parasites, including
Necator americanus [21], Ancylostoma ceylanicum [20], Teladorsagia
circumcincta [22] and Heligmosomoides polygyrus, [6]. There have also
been reports where assay sensitivity and/or specificity was
unsatisfactory e.g. detection of Strongyloies ratti [23], Haemonchus
contortus [24] and Ostertagia ostertagi [25]. With the exception of the
O. Ostertagia assay, assays of satisfactory performance have
employed specific antiserum raised against excretory/secretory
(E/S) antigens of the respective parasites, rather than utilizing
antiserum raised against total somatic antigen. However, the
usefulness of these assays in the detection of heterologous antigen
in human infections, or in the development of an assay to detect
human nematode infection has not been reported.
In this study, polyclonal antiserum was raised against S. Ratti E/
S antigens and used to develop an assay capable of detecting
Strongyloides antigen present in the feces of rodents harbouring S.
Ratti. This assay was then tested in a pilot proof of principle study
in a human patient with patent S. Stercoralis infection. The
sensitivity of the antibody for detection of S. Ratti antigen as well as
heterologous S. Stercoralis coproantigen was investigated. Tech-
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explored, and the analytical specificity of the coproELISA was
determined by testing E/S and fecal supernatants collected from
other animals or humans with helminth infections. Finally, the
effect of preservation and storage conditions of fecal samples and
coproELISA was investigated.
Materials and Methods
S. ratti life cycle
The S. ratti life cycle was maintained in 4–8 week old male
Wistar rats and infection was established as previously described
[26]. Parasites to establish the life cycle were kindly provided by
Prof. Mark Viney (University of Bristol, UK).
E/S antigen preparation
E/S antigens for immunization was collected from parasitic
adult worms harvested from infected rats 10–14 days post-
infection and rinsed extensively in RPMI (Invitrogen, Carisbad,
CA) containing 200 mg/ml ceftriaxone (Roche, Basel, Switzer-
land), 2.5 mg/ml Amphotericin B (Sigma-Aldrich, St. Louis, MO)
and 400 mg/ml Gentamicin. Cleaned parasitic adult worms were
incubated at 37uCi n5 %C O 2 for 24 hours in 3–4 ml of RPMI
containing 20 mg/ml ceftriaxone, 0.25 mg/ml Amphotericin B and
40 mg/ml Gentamicin in 6 well tissue culture plates (Falcon).
Immediately after incubation, a pre-mixed cocktail of protease
inhibitors (complete, mini-protease inhibitor cocktail, Roche) was
added to a 1X final concentration, and the E/S products stored at
220uC. Frozen E/S products were centrifuged at 3,000 g for
5 min and the supernatant collected. Concentration and dialysis of
E/S was undertaken in Centricon YM-10 devices (Millipore,
Billerica, MA) according to the manufacturer’s instructions.
Protein concentration was determined using a BCA kit (Thermo
Scientific, Waltham, MA).
E/S antigens collected from other helminths
S. stercoralis E/S products were kindly donated by Prof Gerhard
Schad (School of Veterinary Medicine, University of Pennsylva-
nia). Adult worms were collected from an experimentally infected
hamster harboring ,390 parasitic adult worms. E/S products
were collected from these parasitic adult worms as previously
described, and lyophilized. Lyophilized E/S antigens were
reconstituted in distilled water, concentrated and quantitated as
previously described for S. ratti E/S antigens. Schistosoma japonicum
E/S products were collected from 100 pairs of S. japonicum adult
worms that were cultured for 24 hours in RPMI. A. caninum E/S
antigens were kindly provided by Tegan Don (Queensland
Institute of Medical Research, Brisbane, Australia). Adult A.
caninum worms were harvested from the small intestine of
necropsied pound dogs. A. ceylanicum E/S products were donated
by Prof Jerzy Benkhe (University of Nottingham, UK). Adult
worms were harvested from experimentally infected hamsters. All
protein preparations were concentrated, dialysed and quantitated
as previously described for S. ratti E/S antigens.
Uninfected rat feces and fecal samples from S. ratti-infected rats
were collected from laboratory rats housed at the Queensland
Institute of Medical Research. Pooled feces collected from 6 mice
without parasitic infection and 6 mice infected with S. mansoni was
supplied by Mary Duke (Queensland Institute of Medical
Research, Brisbane, Australia). Lyophilized T. muris-infected
mouse fecal supernatant was supplied by Prof. Jerzy Benkhe
(University of Nottingham, UK). Queensland Medical Laborato-
ries (Brisbane, Australia) supplied anonymous uninfected human
feces and three consecutive S. stercoralis-infected stool samples.
These had been collected from a single patient with S. stercoralis
infection proven by agar plate coproculture.
Fecal supernatants
Fecal supernatants were prepared at a ratio of 1:3 (v/v) in a
solution of PBS-T (PBS containing 0.3% Tween-20), 4% formalin
or 10% formalin, and vortexed to homogenise in a 50 ml conical
tube. Samples were centrifuged at 3,200 g for 15 min at 4uC, after
which supernatant was collected and centrifuged to remove fecal
debris. The cleared supernatants were then aliquoted and stored at
220uC unless otherwise specified.
Rabbit polyclonal anti-E/S antibody (a-E/S-Ab)
A New Zealand white rabbit was immunized with lyophilized S.
ratti E/S products at the Institute for Medical and Veterinary
Sciences (Adelaide, Australia). The rabbit was bled prior to
immunization to provide a negative control. The primary
immunization consisted of 400 mg E/S antigen emulsified in
Freund’s complete adjuvant, injected subcutaneously. The anti-
body response was boosted with 200 mg E/S antigen emulsified in
Freund’s incomplete adjuvant and injected sub-cutaneously.
Terminal bleed serum was shipped overnight at 4uC to the
laboratory prior to aliquotting and storage at 280uC.
Purification of immunoglobulins
Protein A sepharose (GE Healthcare, Chalfont St. Giles, United
Kingdom) was used to purify a-E/S immunoglobulin from serum
according to the manufacturer’s instructions. IgG was eluted from
the Protein A column by the addition of 1 ml 0.1 M glycine
(pH 3.0). The eluate was immediately neutralized in 60 ml1M
Tris (pH 9.0) and separated into ten separate fractions. Optical
density was monitored by spectrophotometry at a wavelength of
320 nm to identify fractions containing IgG. These were pooled
and dialysed by four changes of PBS in Centriprep YM-50
concentrators (Millipore). Purified a-E/S Ig was quantitated by
spectrophotometry where 1 mg/ml Ig =A320 of 1.43 [27].
Biotinylation of purified a-E/S immunoglobulins (a-E/S-B)
In a 1.5 ml tube, 1.63 mg of a-E/S Ig was diluted in 100 ml
NHS-LC biotin working solution (0.1 mg NHS-LC biotin
Author Summary
Strongyloides stercoralis is almost unique among human
nematode infections in its ability to replicate within a
patient’s body, potentially leading to life-long infections if
left untreated. Given the potential for severe life threat-
ening Strongyloides infections and the unsatisfactory
results of current parasitologic and antibody tests, there
is a need for more efficient diagnostic tools. In this study
we generated an assay to specifically detect proteins
expelled by Strongyloides. Initially this assay for Strongyloi-
des detection was not specific for the parasite; however,
after developing a methodology using formaldehyde
preservation of feces we specifically detected Strongyloides
antigens in rodent and human stool. This methodology
was then tested for cross-reactivity with purified proteins
from closely related parasites and furthermore for cross-
reactivity against faeces collected from animals harbouring
single parasitic infections. Using this approach we found
no non-specific reactivity with host or to various parasite
antigens, suggesting that this assay is truly specific for
Strongyloides detection.
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brought up to 1.1 ml with PBS and biotinylated according to the
manufacturer’s instructions. Unbound biotin was removed, and
the biotinylated anti-E/S antibody was dialysed by centrifugation
in a 30 kDa nanosep spin column (Pall Life Sciences, USA) at
10,000 g at 4uC. Biotinylated a-E/S antibody was recovered from
the spin column by washing the membrane with 500 ml PBS and
collecting the retained immunoglobulins. Biotinylated a-E/S
antibody was aliquotted and stored at 280uC. Biotinylation was
confirmed by dot blot analysis of labelled immunogobulin.
Coproantigen ELISA
The assay components were titrated by doubling dilution to
determine optimal signal:noise ratios. 96 well flat bottom
microtiter plates (Nunc, Thermo Scientific) were coated with
50 ml( 5 mg/ml) a-E/S Ig diluted in coating buffer (15 mM
Na2CO3, 35 mM NaHCO3, pH 9.6) and incubated overnight at
4uC or at room temperature for 90 min. After incubation, wells
were washed 4–5 times in PBS-T (PBS containing 0.05%
Tween20). Wells were then blocked with 150 ml of PBS containing
2% casein (Merck, San Diego, CA) for 60 minutes at room
temperature. Uninfected rat fecal supernatant (nRFS) and infected
fecal supernatants (iRFS) were diluted 1:4 in PBS unless otherwise
specified, and 50 ml added to each well and incubated for 90 min
at room temperature. Known positive and negative formalin-fixed
rat fecal supernatants, E/S products diluted in PBS and uninfected
formalin-fixed fecal supernatant were assayed in duplicate. Wells
containing only PBS or nRFS were included on each plate for
standardization. Plates were then washed 4 times in PBS-T, after
which 50 ml of 1:500 a-E/S-B was added, and incubated at room
temperature for 60 min. The plates were again washed 4 times in
PBS-T and 50 ml of NeutrAvidin-HRP (Thermo Scientific) diluted
1:10,000 was added, and the plates incubated for a further 60 min
at room temperature. Plates were then washed 4 times in PBS-T
prior to the addition of 100 ml per well of the developing sub-
strate, ABTS (2,29-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)).
After incubation at room temperature for 20–30 min plates were
read on a Versamax microplate reader (Molecular Devices) at
405 nm, and analysed with Prism 4 (Graphpad software, La Jolla,
CA).
Ethics
Approval for maintenance of the life cycle of S. ratti in
laboratory rats was obtained from the Animal Ethics Committee
of the Queensland Institute of Medical Research. Ethical approval
to test anonymised, non-reidentifiable fecal samples from patients
with known parasitologic status for strongyloides was granted by
the Royal Brisbane and Womens Hospital Human Research
Ethics Committee.
Results
Sensitivity of the coproantigen ELISA
Polyclonal rabbit antiserum was initially raised against S. ratti
E/S products (a-E/S Ab). This antiserum had an end titer of
1:512,000 when measured by ELISA and was shown to recognise
14 protein bands on western blot (Figure 1A). Reactivity to adult
worm antigen was lower, with only 4 protein bands recognised by
western blot. Even less immunoreactivity was observed with
infective 3
rd stage larvae where no reaction by immunoblot was
observed (Figure 1A). We next characterised a-E/S Ab using
immunohistochemistry to identify the target organs. This resulted
in specific immuno-staining of the ovaries and intestine of the
parasitic adult worm (Figure 1B). It was also apparent that during
Figure 1. Immunoreactivity of the a-E/S antibody is primarily specific for adult S. ratti E/S. a-E/S IgG recognizes primarily Strongyloides E/S
antigens (A): Western blot analysis of (E/S) adult worm E/S, (AWAg) adult worm antigen, (L3Ag) 3
rd stage larval antigen and (RGAg) soluble naı ¨ve rat
gut antigen, using a-E/S IgG at a dilution of 5.5 mg/ml. A single immunodominant ,75 kDa cross-reacting band was observed in the uninfected rat
faecal supernatant immunoprecipitation experiment. Other immunoreactive protein bands are recognised by the a-E/S Ab and are not seen in
uninfected rat gut extract. These S. ratti-specific proteins were detected at approximate molecular weights of 38 kDa, 40 kDa, 60 kDa and 70 kDa in
AWAg, with additional 35 kDa, 50 kDa, 65 kDa, 100 kDa and .100 kDa bands being observed in E/S. (B) Immunoperoxidase-stained parasitic adult
worm sections, probed with either (upper panel) 1:500 preimmune rabbit serum, or (lower panel) a-ES IgG diluted 5.5 mg/ml in PBS. Scale bar
=20mm. Legend: I= intestine; Ov = ovaries; C= cuticle. Arrows highlight the specific ovarian and intestinal cells recognised by this antibody.
doi:10.1371/journal.pntd.0000955.g001
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proteins had occurred, resulting in the generation of an antibody
response to contaminating rodent host antigen (Figure 1A).
An antigen capture assay was developed using purified IgG of
a-E/S Ab (a-E/S IgG) for the capture antibody; the same antibody
now biotinylated was used for detection. To determine the lower
limit of detection of this assay, Strongyloides E/S products were
diluted in PBS from $2 mg/ml to ,10 ng/ml by doubling dilution,
and tested in the antigen-capture ELISA. The lower limit of E/S
detection was determined to be 80 ng/ml for S. ratti; the limit of
detection for and heterologous S. stercoralis antigen was 500 ng/ml.
We next tested whether fecal components interfered with assay
performance. PBS-T-extracted uninfected human fecal superna-
tant (nHFS), uninfected rat fecal supernatant (nRFS) and infected
rat fecal supernatant (iRFS) were evaluated at concentrations
ranging from undiluted to 1:8 in PBS (data not shown). High
background was observed in nRFS across all dilutions, making it
impossible to discriminate between uninfected and infected
samples. At the starting dilution, nHFS exhibited moderate assay
background but became negative at a dilutions $1:4.
Various techniques were evaluated in an attempt to reduce
coproantigen ELISA cross-reactivity. These included a range of
blocking agents, sample diluents, the addition of protease
inhibitors, adsorption against host proteins and heat treatment.
However, the majority of approaches had no effect on the
background when tested with PBS-T-extracted feces. Likewise,
changing the blocking agent from casein to bovine serum albumin,
skim milk or fetal calf serum did not improve the assay
performance. The addition of a commercial cocktail of protease
inhibitors to fecal extracts did not decrease the background,
suggesting proteases were not affecting the assay performance by
desorbing protein coating the plate (data not shown). Pre-
adsorption of cross-reactive antibodies using a cocktail of rat gut
antigen and nRFS resulted in some reduction of cross-reactivity
with host proteins but did not enable reliable distinction between
infected and uininfected samples (data not shown).
It was observed that changing the fecal extraction diluent from
PBS to formalin resulted in a significant beneficial effect on assay
background (Figure 2A), such that when fecal samples were
extracted in formalin, a clear discrimination between uninfected
and infected samples was apparent, with only infected rat feces
testing positive. Again, the addition of FCS and heat treatment
resulted in no significant improvement in assay performance.
Using formalin extraction, the assay was sufficiently sensitive to
detect infection in samples diluted at least eight-fold. However,
assay sensitivity was reduced approximately 4 fold when E/S was
diluted in formalin-extracted nRFS (Figure 2B).
Specificity of coproantigen detection
We next assessed analytical specificity of the assay. Known amounts
of E/S collected from Ancylostoma caninum, A. ceylanicum and Schistosoma
japonicum adult worms were tested at concentrations ranging from
100 mg/ml to 12.5 mg/ml. No cross-reactivity was observed from the
E/S of species of helminth tested, even at concentrations as high as
100 mg/ml (Figure 3A). Likewise, fecal supernatants from mice with
monoparasitic infections Trichuris muris and S. mansoni which are more
likely to co-infect humans and Formalin-fixed feces collected from
uninfected human, tested negative (Figure 3B).
Coproantigen present in fecal supernatants are not
stable after storage at 4uC
To explore the stability of coproantigen for subsequent detection
inS.ratti-infected ratfeces, the effect ofstorageonfecal supernatants
was investigated. Stability was investigated by incubating unpro-
cessed feces stored in formalin and processed feces as formalin-
extractedfecal supernatant at 4uC for various lengths of time. Other
formalin-extracted fecal supernatants were stored in aliquots at
220uC. Frozen formalin-extracted nRFS pooled from 6 rats
consistently tested negative. In contrast, frozen formalin-extracted
iRFS consistently tested positive by coproELISA (Figure 4A).
The effect of prolonged storage at 4uC of formalin-extracted fecal
supernatant,andunprocessedformalin-preservedS.rattiratfecesfor
Figure 2. Formalin preservation allows specific discrimination of infected rat fecal supernatant from uninfected fecal supernatant.
(A) Effect of assay specificity after various treatments. Pooled uninfected fecal supernatant collected from 6 rats (nRFS) and infected rat fecal
supernatant collected from 2 rats infected with S. ratti (13 and 21 dpi) (iRFS) were extracted simultaneously in PBS-T and 4% formalin (4%F). Only
extraction in formalin led to a positive discrimination between nRFS and iRFS. All points are mean 6 SEM of OD values obtained from duplicate
samples. (B) Detection of known amounts of E/S products diluted in PBS or uninfected rat fecal supernatant (nRFS) extracted in 4% formalin. The
lowest concentration of E/S products detected was 80 ng/ml and 325 ng/ml when diluted in PBS and nRFS, respectively. All points are mean 6 SEM
of OD values obtained from 4 samples.
doi:10.1371/journal.pntd.0000955.g002
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formalin-extracted fecal supernatants were tested, both uninfected
and infected rat feces extracted in 10% formalin tested negative.
Feces collectedsimultaneously from bothuninfectedratsand S. ratti-
infected rats, tested positive when extracted in 4% formalin,
indicating that some assay cross-reactivity occurred at sub-optimal
concentration of formalin. In contrast, S. ratti-infected rat feces
stored unprocessed in formalin tested positive when extracted as
fecal supernatant, whereas uninfected rat feces stored unprocessed
in formalin consistently tested negative even after 270 days at 4uC.
S. stercoralis coproantigen can be detected human
infection
Fecal samples collected from a human subject with proven S.
stercoralis infection diagnosed by the agar plate method were tested
next. Three separate samples were processed within 24 hours of
collection. One gram of each stool was subject to concentration by
sodium nitrate flotation for parasitological diagnosis of infection
[28]. In addition, approximately 20% of the first and second stool
samples were tested by Baermann coproculture. All 3 samples
tested negative in 8 coverslips of sodium nitrate-floated feces for
the presence of Strongyloides and all samples tested negative using
the Baermann migration test.
Figure 4B shows the results of the assay in which the three
formalin-extracted human samples were tested with coproantigen
ELISA from dilutions of 1:2 to 1:8. In this experiment, a 1:4
dilution of formalin-fixed nHFS was used as the negative control
and the cut-off threshold for the assay determined. Uninfected
human feces extracted in 10% formalin yielded a positive result at
the assay cut-off when assayed at a 1:2 dilution, but remained
Figure 3. No cross reactivity is observed with purified E/S antigens or faecal supernatants collected from various helminths.
(A) Testing of the Strongyloides coproELISA with E/S products collected from other helminths. All Ancylostoma and Schistosoma E/S products tested
negative even at the high concentration of 100 mg/ml. Pooled uninfected rat fecal supernatant collected from 6 rats (nRFS) and infected rat fecal
supernatant (iRFS) collected from two rats (13 and 21 days post infection). iRFS and 1.3 mg/ml S.ratti E/S (+) tested positive. All points are mean 6 SEM
of OD values obtained from 4 identical samples. (B) Specificity for Strongyloides coproantigen detection. White bars and black bars represent data
from two different experiments. Diluted samples were prepared from undiluted fecal supernatant to 1:4 by doubling dilution in PBS. Uninfected
mouse fecal supernatant (nMFS), Trichuris muris and Schistosoma mansoni supernatants test negative even when applied undiluted. Uninfected rat
fecal supernatant (nRFS) and infected rat fecal supernatant (iRFS) tests negative and positive, respectivly. All points are mean 6 SEM of OD values
obtained from duplicate samples. Assay cuttoff for negative reading is represented by the grey box.
doi:10.1371/journal.pntd.0000955.g003
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samples tested positive at dilutions of 1:2 and 1:4, while sample the
third tested positive at all dilutions. When extracted in 10%
formalin, all test samples tested positive for coproantigen, even
when diluted 1:8.
Discussion
Prior to this study, there had been one report describing
coproantigen detection for S. ratti. In this work, antiserum was
raised against whole worm antigen of S. ratti larvae and parasitic
adult worms [23]. However, the authors reported low signal:noise
ratios for positive fecal samples and minor cross-reactivity with the
nematodes Syphacia muris and Necator americanus. The observation of
high assay background is likely due to contamination of the
antigen preparation with host gut and fecal material. Thus, the
assay was not considered sufficiently sensitive for use as a
diagnostic test [23]. More recently coproantigen tests have used
antiserum raised to E/S antigens for the diagnosis of animal
nematode infections. In general this approach has proved to be
more useful [6,20,22].
An objective of this study was to determine whether
heterologous S. stercoralis coproantigen could be detected in an
infected human with antiserum raised to rodent Strongyloides E/S
antigens. Data supporting this approach included studies docu-
menting cross-reactivity between species with various published
serodiagnostic and coproantigen assays [4,21,29,30]. Although,
there have been numerous reports of the detection of coproantigen
in animal nematode infections [6,20,22], to our knowledge this is
the first report that heterologous human infection has been
detected by coproELISA with antiserum raised to antigens from
an animal nematode.
The anti-Strongyloides E/S polyclonal antibody was observed to
cross-react with contaminating rat gut proteins present in rat feces.
This cross-reactivity resulted in false positive tests when fecal
supernatants collected from control rats were tested by coproE-
LISA. Cross-reactivity with fecal components is a common
occurrence in coproantigen assays and many techniques have
been published describing how to reduce cross-reactivity
[6,22,31,32]. Published methods for reducing background in
coproELISAs are aimed at improving specificity by adsorbing
cross-reactive antibodies, optimising method for extraction of the
target antigen including the diluent used for fecal supernatant, or
the choice of assay blocking agent. A range of these methods was
tested with the Strongyloides a-E/S indirect coproELISA. However,
the only method that reliably reduced assay background while
preserving a positive signal in infected feces was formalin
extraction of fecal supernatants. A possible explanation for this is
that formalin treatment resulted in cross-linking the epitopes of the
cross-reactive antigens in such a way that the non-specific
antibodies in a-E/S Ab no longer bound. An alternative
hypothesis is that the host antigens are fixed to host debris that
are removed by centrifugation. Coproantigen detection in
formalin-extracted fecal supernatant has also been successfully
applied for diagnosis of Giardia [33], Echinococcus [8,29], Taenia [34]
and Cryptosporidium [35].
An important consideration in the Strongyloides coproantigen
ELISA is the use of formalin-extracted fecal supernatant for the
Figure 4. Effect of sample storage on rat fecal supernatant and
detection of heterologous S. stercoralis coproantigen. (A) Pooled
uninfected rat fecal supernatant collected from 6 rats (nRFS) and
infected rat fecal supernatant (iRFS) collected from two rat (13 and 21
dpi) had previously been stored at 220uC and consistently tested
negative and positive, respectively. Numbered samples 123, 150, 151,
160 and 161 represent samples collected from rats infected with known
amounts of S. ratti infective larvae. Extracted fecal supernatant stored at
4uC displayed erratic absorbance values, as fecal supernatants from
both uninfected and infected rats test positive. All unprocessed S. ratti
infected feces stored in formalin (4% or 10%) tested positive for
coproantigen when extracted after storage. Uninfected rat fecal feces
tested negative when stored unextracted. All points are mean 6 SEM of
OD values obtained from duplicate samples. (B) Uninfected human fecal
supernatant (nHFS) and Strongyloides-infected human fecal superna-
tants collected daily from a single patient with clinically diagnosed
strongyloidiasis (SS01-SS03) were extracted simultaneously with 4%
formalin and 10% formalin. All points are mean 6 SEM. Assay cuttoff for
negative reading is represented by the grey box.
doi:10.1371/journal.pntd.0000955.g004
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formalin exerts its effect by protein cross-linking. Thus, the
sensitivity of E/S product detection in formalin-extracted feces
could be impaired. This hypothesis was confirmed in an
experiment where purified S. ratti E/S was diluted in PBS and
formalin fixed uninfected faecal supernatant. An additional
advantage of this preservation method is that it removes potential
biohazards. Dilution of E/S in unfixed faecal supernatant has also
been demonstrated to decrease assay signal:noise ratio and may be
a contributing factor in the decreased sensitivity [6,20,33].
Even though the sensitivity for detection of S. stercoralis E/S
(0.5 mg/ml) was approximately 6 fold less than the detection limit
for S. ratti E/S (0.08 mg/ml). The sensitivity of nematode
coproELISAs currently range from 0.01 mg/ml to 0.5 mg/ml E/
S [6,20,22], which is in agreement with the observed sensitivity of
the Strongyloides coproELISA.
An important hurdle in diagnostic assays for parasitic infections
is cross-reactivity with antibodies or antigens from heterologous
parasites, a major issue described in many nematode coproantigen
and serodiagnostic assays including current Strongyloides antibody
tests [22,36]. No cross reactivity was observed in experiments with
E/S antigens from S. japonicum, murine S. mansoni fecal superna-
tants or samples from the more closely related nematodes A.
caninum and A. ceylanicum, or fecal supernatants from mice
harboring T. muris infection. Together, these experiments suggest
that the assay is specifically detecting Strongyloides antigens, as no
cross-reactivity was noted with the other helminths tested.
The last and most important investigation of the Strongyloides
coproantigen ELISA involved testing S. stercoralis-infected and
-uninfected human fecal samples. Importantly all S. stercoralis-
infected samples extracted in 4% or 10% formalin tested positive
when assayed at the standard sample dilution of 1:4. Two fecal
supernatants extracted in 4% formalin tested negative when
diluted further to 1:8. However, when simultaneously extracted in
10% formalin the samples tested positive. This suggests that this
assay is more robust when fecal supernatant is extracted at the
common fixative concentration, 10% formalin. This finding is
similar to that reported by [33]where fixation in 10% formalin
increased ELISA values in comparison with ELISA values
obtained with distilled water extracted supernatants.
Finally, the stability of coproantigen after prolonged storage was
addressed. A few reports have examined the apparent stability of
coproantigen after prolonged storage at 4uC and 280uC, as well
as following environmental desiccation of fecal samples [6,20,37].
The results of the data from this study suggest that antigens present
in formalin-extracted fecal supernatants are not stable when left at
4uC, but were so when stored at 220uC. Interestingly, when
infected feces were stored in formalin at 4uC for at least 6 months
prior to fecal supernatant extraction they tested positive. This
suggests that the coproantigens are stable when feces are preserved
in formalin and stored at 4uC, but are not stable when fecal
supernatant was extracted prior to refrigerated storage. These
results contrast to a similar study where formalin extracted and
water extracted faecal supernatants were both stable at 4uC for the
detection of Giardia cyst antigens [33].
The Strongyloides antigens detected by the coproELISA are
currently undefined and future work in identifying the actual
antigen(s) and raising monoclonal antibodies should enhance assay
sensitivity and eliminate host cross-reactivity. The efficacy of the
coproELISA is likely to be greatly enhanced if host cross-reactivity
is eliminated and unfixed samples could also be assessed,
broadening the utility. Another advantage of developing the
Strongyloides coproantigen monoclonal antibodies would be in the
conversion of the coproELISA into a rapid immunochromato-
graphic dipstick test, a number of which are commercially
available [38]. Further studies with a wider population of patients
harbouring a variety of monoparasitic infections will also be
required to accurately determine the specificity and sensitivity of
the coproELISA.
In conclusion, we have developed a coproELISA for the
detection of strongyloidiasis, and have demonstrated that coproE-
LISA using antibodies raised against antigens of a related animal
parasite can be used to diagnose human infection in an antigen
capture ELISA. Furthermore, this is the first report of an antigen
capture assay using antibodies raised against native Strongyloides E/
S antigens. Unlike many published assays where fecal supernatant
is extracted in PBS containing a non-ionic detergent [6,16,20,
22,29], the current assay was only effective in discriminating
uninfected from Strongyloides-infected fecal supernatant when
extracted from formalin-treated feces. Future work with this assay
will lead to a better diagnosis of human infection and enhanced
understanding of the biochemistry of Strongyloides infections.
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